Welcome to our dedicated page for KAYA HOLDINGS news (Ticker: KAYS), a resource for investors and traders seeking the latest updates and insights on KAYA HOLDINGS stock.
KAYA HOLDINGS INC (symbol: KAYS) has been operating for over four decades, with a strong presence in various sectors, including hospitality, civil aviation, construction, retail, energy, and agriculture. With 8 companies and more than 4,000 employees, KAYA prioritizes guest and customer satisfaction. The company is on a mission to be the pioneer of excellence in all its endeavors, focusing on international expansion and creating synergy across its business lines for significant growth.
Kaya Holdings (OTCQB:KAYS) and The Sacred Mushroom™ announce their first Open House event on December 27, 2024, from 5:00 PM to 8:00 PM at their Portland psilocybin treatment center. The event will showcase private treatment rooms, an indoor garden, and various therapeutic activities. The company is also launching a new series called 'Community, Culture, and a Touch of Psilocybin', featuring group sessions focused on low-dose psilocybin experiences combined with artistic appreciation.
The facility has released a free e-book titled 'Is Psilocybin Right for You?' covering various topics including therapeutic benefits, dosing, risks, and applications for conditions such as PTSD, depression, anxiety, and addiction. Attendees will have the opportunity to reserve spots for upcoming sessions at special introductory rates.
The Sacred Mushroom™ (TSM), operated by Kaya Holdings, announced the release of its first e-book, "Is Psilocybin Right for You?". This e-book is part of a planned series aimed at educating the public on the therapeutic benefits of psilocybin for mental health and personal growth. Topics covered include the history of psilocybin, its effects on the brain, and its potential benefits for conditions such as PTSD, depression, anxiety, and more. The e-book is accessible online or can be downloaded for offline reading. TSM, a licensed psilocybin treatment center in Portland, Oregon, offers a curated environment for transformative psychedelic experiences. CEO Craig Frank emphasized the importance of providing information to help individuals make informed decisions about psilocybin treatments. For more details or to book an appointment, visit the TSM website.
Kaya Holdings, Inc. (OTCQB:KAYS) criticizes the FDA's rejection of MDMA therapy for PTSD and proposes psilocybin as an alternative treatment. KAYS operates The Sacred Mushroom™, an 11,000 sq. ft. legally licensed psilocybin treatment center in Portland, Oregon. CEO Craig Frank invites researchers and individuals to consider psilocybin treatment at their facility. Emerging research suggests psilocybin's potential in treating PTSD, with studies showing reduced symptoms after just one or two sessions. Compared to MDMA, psilocybin offers longer sessions, milder side effects, and a preferred safety profile regarding abuse potential and dependency risk. The company emphasizes that psilocybin is not federally legal in the US and advises consulting a physician before making changes to prescription drug treatments.
Kaya Holdings (OTCQB:KAYS) announced the grand opening of its licensed psilocybin treatment center, The Sacred Mushroom (TSM), in Portland, Oregon, on July 5, 2024. The center will begin administering psilocybin treatments to eligible guests, offering an alternative pathway to better health for individuals suffering from PTSD, depression, OCD, anxiety, addictions, eating disorders, and other treatment-resistant mental health disorders. KAYS CEO Craig Frank will be the first to undergo the treatment. The facility aims to provide a premium legal psilocybin experience. For appointments or information, visit The Sacred Mushroom temporary web page or email info@tsmpdx.com.
KAYS encourages stockholders to update their contact information for future updates.
Kaya Holdings, Inc. (OTCQB:KAYS) announced that its subsidiary, Fifth Dimension Therapeutics, has started accepting appointments at The Sacred Mushroom (TSM) Psilocybin Treatment Center in Portland, Oregon. The center provides customized treatments for mental health issues such as PTSD, anxiety, trauma, and addictions. TSM offers proprietary 'Synergy by Design' experiences and group sessions. KAYS CEO Craig Frank emphasized the transformative potential of psilocybin. Recent studies support its effectiveness in treating mental health conditions. The U.S. behavioral health market is projected to exceed $136 billion by 2032. KAYS aims to establish itself in the psychedelic medicine field through its treatment centers.
Kaya Holdings, Inc. (KAYS) has been awarded a license to operate a Psilocybin Service Center in Oregon, becoming the first state in the US to allow Psilocybin administration in a legal setting. Through its subsidiary Fifth Dimension Therapeutics, KAYS will launch The Sacred Mushroom, a psychedelic treatment facility offering innovative experiences. The facility is set to open within the next thirty days in downtown Portland, covering 11,000 square feet. Psilocybin, a compound in magic mushrooms, has shown promise in treating various mental health conditions. KAYS aims to be a leader in psychedelic care delivery, offering a unique guest experience. The US behavioral health market is growing, creating opportunities for companies like KAYS to provide alternative therapies.
FAQ
What is the current stock price of KAYA HOLDINGS (KAYS)?
What is the market cap of KAYA HOLDINGS (KAYS)?
How long has KAYA HOLDINGS INC been operating?
In how many sectors is KAYA HOLDINGS INC active?
How many employees does KAYA HOLDINGS INC have?
What is the mission of KAYA HOLDINGS INC?
